Friday, February 26, 2021

Latest:

Brightfield & Multispectral Fluorescence Imaging and Spectral Unmixing
Laboratory Blender for Research and Development
Multifunctional Container Blenders for Pharmaceutical Production
Proprietary Hydrogel Deposition and Demoulding Manufacturing Processes
Hammer Mills for Pharmaceutical Solids Production

Pharma Industry Review

Events
Companies
Resources
Sectors
DISEASES
Investment
- Stocks
Projects
COVID-19

Respiratory

New analysis proposes Severe COVID-19 is a Microvascular Disease

September 29, 2020September 30, 2020 Pharmaceutical Industry Editor monoclonal antibodies

The range of clinical responses to SARS-CoV-2 infection is extremely broad, a factor making the disease particularly difficult to properly

Clinical Trials COVID-19 DISEASES Infectious Diseases Latest Respiratory

Corticosteroid Dexamethasone could be a lifeline for COVID-19 patients

June 18, 2020June 23, 2020 Pharmaceutical Industry Editor Drug repurposing, generic drugs, steroids

The initial Dexamethasone clinical trial outcomes in the UK have demonstrated that the generic corticosteroid medication could present a lifeline

Clinical Trials COVID-19 DISEASES Infectious Diseases Latest Respiratory

Reinstated hydroxychloroquine study reveals the dangers of rushed trials

June 13, 2020July 8, 2020 Pharmaceutical Industry Editor Drug repurposing, generic drugs

The World Health Organisation (WHO) halted one arm of the hydroxychloroquine COVID-19 Trial at the end of May, only to

Clinical Trials COVID-19 DISEASES Infectious Diseases Latest Regulatory Respiratory

Algernon gets FDA nod for human study of Ifenprodil for COVID-19

June 13, 2020June 23, 2020 Pharmaceutical Industry Editor Drug repurposing, receptor antagonist

Algernon has received the FDA’s approval for the commencement of a Phase 2 and 3 human study of it’s repurposed

Clinical Trials COVID-19 DISEASES Infectious Diseases Press Releases Respiratory Sponsored

ACTide EDC (Electronic Data Capture) System against COVID-19

May 18, 2020May 18, 2020 Pharmaceutical Industry Editor

Nubilaria, a forward thinking clinical data management company, has released an important announcement for Researchers and Health Professionals in Europe

Clinical Trials COVID-19 DISEASES Infectious Diseases Latest R&D Respiratory Sponsored

Nubilaria provides free EDC for pro bono COVID-19 related ARDS study

April 29, 2020May 6, 2020 Pharmaceutical Industry Editor

Nubilaria is providing it’s innovative ACTide EDC system free in support of a clinical study for COVID-19 related ARDS intensive

Clinical Trials COVID-19 DISEASES Drug Development Infectious Diseases Press Releases R&D Regulatory Respiratory

Altasciences completes Gimsilumab Phase I study for ARDS in COVID-19

April 13, 2020June 23, 2020 Pharmaceutical Industry Editor monoclonal antibodies

Canadian Altasciences completes its Phase I study on Gimsilumab to prevent and treat acute respiratory distress syndrome (ARDS) in COVID-19

COVID-19 Infectious Diseases Latest Manufacturing Regulatory Respiratory Supply Chain

EU waiving VAT and customs duty on critical medical devices

April 4, 2020April 4, 2020 Pharmaceutical Industry Editor

The European Commission has waived customs duty and VAT on medical devices imported from non-EU countries. A decision has been

Clinical Trials COVID-19 DISEASES Drug Development Infectious Diseases Inflammatory Diseases Latest Manufacturing Regulatory Respiratory

Roche’s Actemra (tocilizumab) shows “excellent effects” against COVID-19

March 28, 2020September 21, 2020 Pharmaceutical Industry Editor

The widely used arthritis medicine Actemra (tocilizumab) has demonstrated “excellent effects” in the treatment of the COVID-19 disease. Roche’s promising

Kaletra (lopinavir/ritonavir) therapy researcg

Clinical Trials COVID-19 DISEASES Drug Development Infectious Diseases Latest R&D Respiratory

Kaletra (lopinavir/ritonavir) disappoints as treatment for severe COVID-19

March 22, 2020March 22, 2020 Pharmaceutical Industry Editor

Kaletra, a medicine containing two HIV drugs, lopinavir and ritonavir, which was considered as a potential treatment for the novel

← Previous

Ticker Tape by TradingView

Please leave this field empty

DON’T MISS A THING

Be the first to receive the latest news from the pharma industry

We don’t spam! Read our Privacy Policy for more info.

Check your inbox or spam folder to confirm your subscription.

Featured Company

FEATURED
Ectica Technologies

New

Featured

Category: Assays, Drug Discovery and Laboratory Equipment

Next-gen hydrogel-based tools and specialty chemicals Details Products Downloads Videos Press Releases Contact Details Ectica Technologies is an innovative manufacturer and supplier of hydrogel-based tools and specialty chemicals for drug discovery, research, and manufacturing applications in the pharmaceutical, biotech and life sciences industries.Ectica offers modern ready-to-use solutions to advance drug development and R&D programs such as the 3DProSeed™ hydrogel microtitre Read more…

LATEST

Drug Development Immunology Neurology Oncology Preclinical Studies Products R&D

Brightfield & Multispectral Fluorescence Imaging and Spectral Unmixing

February 24, 2021February 24, 2021 Pharmaceutical Industry Editor

The cutting-edge multispectral tissue cytometry hardware TissueFAXS SPECTRA, developed by TissueGnostics, has the unique ability to enable multispectral imaging of

Manufacturing Products

The cutting-edge multispectral tissue cytometry hardware TissueFAXS SPECTRA, developed by TissueGnostics, has the unique ability to enable multispectral imaging of

About Us

Pharma Industry Review is here to provide you with the latest news, reviews and insights from the pharmaceutical industry so that you can take your business one step ahead.

About Us

Contact Us
Editorial Standards
Terms & Conditions
Privacy Policy
Users

Useful Links

Client Portal
Advertise
Presentation Portal
Sectors
Projects

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits, according to our Privacy Policy. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

SAVE & ACCEPT

);